Latest Myriad Genetics (MYGN) Headlines
Myriad Genetics Down on Court Ruling - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 2:30PM CDT
Shares of Myriad Genetics slashed 8.34% at yesterday's close, soon after an unfavorable court bid.
Moving Average Crossover: Great News for Myriad Genetics (MYGN)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 9:28AM CDT
Moving Average Crossover: Great News for Myriad Genetics (MYGN)?
Dividend, Financial Results, Publishing of Clinical Study Data, New Offerings and Conference Call Schedules - Analyst Notes on H&R Block, Ulta Beauty, Myriad, QIAGEN, and Nutrisystem
PR Newswire - Wed Mar 12, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding H&R Block Inc. (NYSE: HRB), Ulta Salon, Cosmetics & Fragrance, Inc. (NASDAQ: ULTA), Myriad Genetics, Inc. (NASDAQ: MYGN), QIAGEN NV (NASDAQ: QGEN), and Nutrisystem Inc. (NASDAQ: NTRI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Myriad falls on rival product
at Investor's Business Daily - Tue Mar 11, 5:47PM CDT
The diagnostic product maker's shares dropped 8.3% to 34.60 the day after a federal court declined to block Ambry Genetics from selling a rival product until a patent case is resolved. Myriad Genetics (MYGN) has been trying to stop the entry of rival...
Watch for Myriad Genetics to Potentially Rebound After Falling 8.34% Yesterday
Comtex SmarTrend(R) - Tue Mar 11, 5:40PM CDT
Myriad Genetics (NASDAQ:MYGN) traded in a range yesterday that spanned from a low of $32.76 to a high of $35.74. Yesterday, the shares fell 8.3%, which took the trading range below the 3-day low of $37.05 on volume of 6.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
After Yesterday's Decline of 8.34%, Myriad Genetics Offers Investors Better Value
Comtex SmarTrend(R) - Tue Mar 11, 5:40PM CDT
Myriad Genetics (NASDAQ:MYGN) traded in a range yesterday that spanned from a low of $32.76 to a high of $35.74. Yesterday, the shares fell 8.3%, which took the trading range below the 3-day low of $37.05 on volume of 6.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
General Motors, Tesla Motors Under Late Pressure
at Investor's Business Daily - Tue Mar 11, 3:56PM CDT
Stocks sold off in the afternoon Tuesday as volume climbed. With no big economic news, investors focused on company-specific news. The Nasdaq finished down 0.6%; the S&P 500 was off 0.5% and the Dow Jones industrial average lost 0.4%. Volume rose...
Stocks Worsen In Late Trade; Ubiquiti Gains
at Investor's Business Daily - Tue Mar 11, 1:59PM CDT
Stocks were at or near Tuesday's worst levels after earlier rebound efforts faded. The Nasdaq was down 0.4%, putting it on pace for its fourth straight loss. It was the only main index to hit a new session low. The S&P 500 was also off by 0.4%, while...
Why Myriad Genetics, Inc. Shares Were Spliced
Sean Williams, The Motley Fool - Motley Fool - Tue Mar 11, 1:44PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Myriad Genetics , a company focused on...
Nasdaq stocks posting largest percentage decreases
AP - Tue Mar 11, 12:29PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Market Rallies; Green Mountain Changes Its Name
at Investor's Business Daily - Tue Mar 11, 10:58AM CDT
After an uncertain open, the stock market rallied Tuesday, up modestly by midday. The Nasdaq rose 0.4%, the S&P 500 was up 0.2% and the Dow Jones gained 0.1%. Volume was up on the Nasdaq, but down on the NYSE. Among IBD 50 stocks, Myriad Genetics...
Myriad Stock Tumbles After Court Allows Rival To Sell
at Investor's Business Daily - Tue Mar 11, 10:18AM CDT
Myriad Genetics (MYGN) stock tumbled in early trading on the stock market today after a court late Monday denied it a preliminary injunction against a rival. Myriad has been trying to stop the entry of rival versions of its BRACAnalysis test for...
Today’s Top Biotech Stories: Myriad Genetics, Bayer, Amgen, and Synta
Leo Sun, The Motley Fool - Motley Fool - Tue Mar 11, 9:27AM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. Let's take a closer look at four companies -- Myriad Genetics...
Stocks Futures Effectively Flat; Boyd Gaming Up, Myriad Dives
at Investor's Business Daily - Tue Mar 11, 7:54AM CDT
Stock futures were narrowly mixed in a relatively quiet premarket session Tuesday. Dow futures backed out of thin, early gains and were a mild 2.7 points below fair market value. S&P 500 futures were flat, and Nasdaq 100 futures, slowly adding to...
Why Myriad Genetics (MYGN) Could Beat Earnings Estimates Again - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 8:10AM CDT
Myriad Genetics, a firm in the Bio-medical industry, could be a great candidate for another earnings beat
The Nasdaq's 5 Most Hated Stocks
Sean Williams, The Motley Fool - Motley Fool - Fri Mar 07, 5:16PM CST
I actually had to do some digging to come up with the date of April 7, 2000 as the last time the technology-heavy Nasdaq Composite closed at a higher point than it did earlier this week. The broader market has been the beneficiary of a strong...
Jim Cramer: Happy Birthday, You Bogus Bull Market
at The Street - Fri Mar 07, 10:22AM CST
You've rallied 177%, yet many don't seem to believe you exist.
Uptrend Call Working As Myriad Genetics Stock Rises 45.9% (MYGN)
Comtex SmarTrend(R) - Fri Mar 07, 9:13AM CST
SmarTrend identified an Uptrend for Myriad Genetics (NASDAQ:MYGN) on January 16th, 2014 at $25.68. In approximately 2 months, Myriad Genetics has returned 45.90% as of today's recent price of $37.46.
Critical Alerts For United Health, Sysco, Nike, Consolidated Edison, and Myriad Genetics Released By InvestorsObserver
PR Newswire - Fri Mar 07, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for UNH, SYY, NKE, ED, and MYGN.
Safeguard Scientifics Announces Fourth Quarter and Full-Year 2013 Financial Results
Business Wire - Thu Mar 06, 5:00AM CST
--Company Increases Share Repurchase Program;
Myriad Genetics Down on Court Ruling - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 2:30PM CDT
Shares of Myriad Genetics slashed 8.34% at yesterday's close, soon after an unfavorable court bid.
Moving Average Crossover: Great News for Myriad Genetics (MYGN)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 9:28AM CDT
Moving Average Crossover: Great News for Myriad Genetics (MYGN)?
Dividend, Financial Results, Publishing of Clinical Study Data, New Offerings and Conference Call Schedules - Analyst Notes on H&R Block, Ulta Beauty, Myriad, QIAGEN, and Nutrisystem
PR Newswire - Wed Mar 12, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding H&R Block Inc. (NYSE: HRB), Ulta Salon, Cosmetics & Fragrance, Inc. (NASDAQ: ULTA), Myriad Genetics, Inc. (NASDAQ: MYGN), QIAGEN NV (NASDAQ: QGEN), and Nutrisystem Inc. (NASDAQ: NTRI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Myriad falls on rival product
at Investor's Business Daily - Tue Mar 11, 5:47PM CDT
The diagnostic product maker's shares dropped 8.3% to 34.60 the day after a federal court declined to block Ambry Genetics from selling a rival product until a patent case is resolved. Myriad Genetics (MYGN) has been trying to stop the entry of rival...
Watch for Myriad Genetics to Potentially Rebound After Falling 8.34% Yesterday
Comtex SmarTrend(R) - Tue Mar 11, 5:40PM CDT
Myriad Genetics (NASDAQ:MYGN) traded in a range yesterday that spanned from a low of $32.76 to a high of $35.74. Yesterday, the shares fell 8.3%, which took the trading range below the 3-day low of $37.05 on volume of 6.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
After Yesterday's Decline of 8.34%, Myriad Genetics Offers Investors Better Value
Comtex SmarTrend(R) - Tue Mar 11, 5:40PM CDT
Myriad Genetics (NASDAQ:MYGN) traded in a range yesterday that spanned from a low of $32.76 to a high of $35.74. Yesterday, the shares fell 8.3%, which took the trading range below the 3-day low of $37.05 on volume of 6.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
General Motors, Tesla Motors Under Late Pressure
at Investor's Business Daily - Tue Mar 11, 3:56PM CDT
Stocks sold off in the afternoon Tuesday as volume climbed. With no big economic news, investors focused on company-specific news. The Nasdaq finished down 0.6%; the S&P 500 was off 0.5% and the Dow Jones industrial average lost 0.4%. Volume rose...
Stocks Worsen In Late Trade; Ubiquiti Gains
at Investor's Business Daily - Tue Mar 11, 1:59PM CDT
Stocks were at or near Tuesday's worst levels after earlier rebound efforts faded. The Nasdaq was down 0.4%, putting it on pace for its fourth straight loss. It was the only main index to hit a new session low. The S&P 500 was also off by 0.4%, while...
Why Myriad Genetics, Inc. Shares Were Spliced
Sean Williams, The Motley Fool - Motley Fool - Tue Mar 11, 1:44PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Myriad Genetics , a company focused on...
Nasdaq stocks posting largest percentage decreases
AP - Tue Mar 11, 12:29PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Market Rallies; Green Mountain Changes Its Name
at Investor's Business Daily - Tue Mar 11, 10:58AM CDT
After an uncertain open, the stock market rallied Tuesday, up modestly by midday. The Nasdaq rose 0.4%, the S&P 500 was up 0.2% and the Dow Jones gained 0.1%. Volume was up on the Nasdaq, but down on the NYSE. Among IBD 50 stocks, Myriad Genetics...
Myriad Stock Tumbles After Court Allows Rival To Sell
at Investor's Business Daily - Tue Mar 11, 10:18AM CDT
Myriad Genetics (MYGN) stock tumbled in early trading on the stock market today after a court late Monday denied it a preliminary injunction against a rival. Myriad has been trying to stop the entry of rival versions of its BRACAnalysis test for...
Today’s Top Biotech Stories: Myriad Genetics, Bayer, Amgen, and Synta
Leo Sun, The Motley Fool - Motley Fool - Tue Mar 11, 9:27AM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. Let's take a closer look at four companies -- Myriad Genetics...
Stocks Futures Effectively Flat; Boyd Gaming Up, Myriad Dives
at Investor's Business Daily - Tue Mar 11, 7:54AM CDT
Stock futures were narrowly mixed in a relatively quiet premarket session Tuesday. Dow futures backed out of thin, early gains and were a mild 2.7 points below fair market value. S&P 500 futures were flat, and Nasdaq 100 futures, slowly adding to...
Why Myriad Genetics (MYGN) Could Beat Earnings Estimates Again - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 8:10AM CDT
Myriad Genetics, a firm in the Bio-medical industry, could be a great candidate for another earnings beat
The Nasdaq's 5 Most Hated Stocks
Sean Williams, The Motley Fool - Motley Fool - Fri Mar 07, 5:16PM CST
I actually had to do some digging to come up with the date of April 7, 2000 as the last time the technology-heavy Nasdaq Composite closed at a higher point than it did earlier this week. The broader market has been the beneficiary of a strong...
Jim Cramer: Happy Birthday, You Bogus Bull Market
at The Street - Fri Mar 07, 10:22AM CST
You've rallied 177%, yet many don't seem to believe you exist.
Uptrend Call Working As Myriad Genetics Stock Rises 45.9% (MYGN)
Comtex SmarTrend(R) - Fri Mar 07, 9:13AM CST
SmarTrend identified an Uptrend for Myriad Genetics (NASDAQ:MYGN) on January 16th, 2014 at $25.68. In approximately 2 months, Myriad Genetics has returned 45.90% as of today's recent price of $37.46.
Critical Alerts For United Health, Sysco, Nike, Consolidated Edison, and Myriad Genetics Released By InvestorsObserver
PR Newswire - Fri Mar 07, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for UNH, SYY, NKE, ED, and MYGN.
Safeguard Scientifics Announces Fourth Quarter and Full-Year 2013 Financial Results
Business Wire - Thu Mar 06, 5:00AM CST
--Company Increases Share Repurchase Program;
